People: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,429.50GBp
22 Aug 2014
Price Change (% chg)

-5.00p (-0.35%)
Prev Close
1,434.50p
Open
1,430.00p
Day's High
1,430.00p
Day's Low
1,420.50p
Volume
5,372,009
Avg. Vol
8,019,512
52-wk High
1,709.00p
52-wk Low
1,365.00p

Search Stocks

Dingemans, Simon 

Brief Biography

Mr. Simon Dingemans is Chief Financial Officer, Executive Director of GlaxoSmithKline plc. Prior to joining GSK, Simon had over 25 years of experience in investment banking at SG Warburg and Goldman Sachs. During this time, he advised a broad range of large corporates across a number of industry sectors, including pharmaceuticals and consumer healthcare. Simon advised GSK for over a decade before his appointment and was closely involved in a number of GSK’s key strategic projects, including the establishment of ViiV Healthcare. Simon is a member of the Corporate Development Council for the National Theatre and Deputy Chairman of the 100 Group.

Basic Compensation

Total Annual Compensation, GBP Long-Term Incentive Plans, GBP All Other, GBP Fiscal Year Total, GBP
1,650,000 1,502,000 140,000 3,292,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Christopher Gent

734,000

Andrew Witty

7,207,000

Simon Dingemans

3,292,000

Moncef Slaoui

8,414,000

Deirdre Connelly

--

Roger Connor

--
As Of 30 Dec 2013
Search Stocks